Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans
- PMID: 15977995
- DOI: 10.2174/1566524054022521
Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans
Abstract
Immunization of mice with a stress mannoprotein of >200 kDa from the cell wall of Candida albicans led to the production of monoclonal antibody (Mab) C7. The immunogen is a major target of secretory IgA and its expression is regulated by different environmental conditions including temperature, pH, glucose concentration and ammonium sulphate in the culture medium. Mab C7 reacted with a peptide epitope present in the >200 kDa antigen as well as in a number of antigens from the blastoconidium and germ tube cell wall, including enolase. In addition to its reactivity with C. albicans, Mab C7 also reacted with antigens present in C. krusei, C, tropicalis, C. glabrata, C. dubliniensis and C. lusitaniae, as well as in Cryptococcus neoformans, Scedosporium prolificans and Aspergillus fumigatus. Mab C7 exhibited four important biological activities, namely inhibition of adhesion of C. albicans to a variety of surfaces, inhibition of germination of C. albicans, direct candidacidal activity and direct tumoricidal activity. In tumor cells, Mab C7 reacted with nucleoporin Nup88, a reactivity that can be utilized for diagnostic and prognostic purposes.
Similar articles
-
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.Infect Immun. 2003 Sep;71(9):5273-9. doi: 10.1128/IAI.71.9.5273-5279.2003. Infect Immun. 2003. PMID: 12933874 Free PMC article.
-
Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.Hybridoma (Larchmt). 2005 Jun;24(3):146-51. doi: 10.1089/hyb.2005.24.146. Hybridoma (Larchmt). 2005. PMID: 15943562
-
Cross-reactivity between Candida albicans and oral squamous cell carcinoma revealed by monoclonal antibody C7.Anticancer Res. 2007 Sep-Oct;27(5B):3639-43. Anticancer Res. 2007. PMID: 17972529
-
Specificity of the monoclonal antibody 3H8 in the immunohistochemical identification of Candida species.Oral Dis. 2006 Jul;12(4):428-33. doi: 10.1111/j.1601-0825.2006.01228.x. Oral Dis. 2006. PMID: 16792731
-
The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.Vaccine. 2017 Oct 13;35(43):5786-5793. doi: 10.1016/j.vaccine.2017.08.082. Epub 2017 Sep 11. Vaccine. 2017. PMID: 28911903 Review.
Cited by
-
Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.PLoS One. 2008 Jun 11;3(6):e2371. doi: 10.1371/journal.pone.0002371. PLoS One. 2008. PMID: 18545659 Free PMC article.
-
Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.Infect Immun. 2007 Jul;75(7):3680-2. doi: 10.1128/IAI.01840-06. Epub 2007 Apr 23. Infect Immun. 2007. PMID: 17452471 Free PMC article.
-
Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans.Antimicrob Agents Chemother. 2011 Jul;55(7):3156-63. doi: 10.1128/AAC.00892-10. Epub 2011 Apr 25. Antimicrob Agents Chemother. 2011. PMID: 21518848 Free PMC article.
-
Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p.FEMS Immunol Med Microbiol. 2008 Nov;54(2):195-202. doi: 10.1111/j.1574-695X.2008.00465.x. Epub 2008 Jul 24. FEMS Immunol Med Microbiol. 2008. PMID: 18662314 Free PMC article.
-
Candidiasis--do we need to fight or to tolerate the Candida fungus?Folia Microbiol (Praha). 2007;52(3):297-312. doi: 10.1007/BF02931313. Folia Microbiol (Praha). 2007. PMID: 17702470 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous